title: [Selection of microRNA for providing tumor specificity of transgene expression in cancer gene therapy].
abstract: The use of tumor-specific microRNA loss to inhibit transgene expression in normal cells is considered as a way to increase the specificity of gene-therapeutic antitumor drugs. This method assumes the introduction of recognition sites of suppressed in tumor cells microRNAs into transgene transcipt. In the presented work, the efficiency of the strategy for providing the tumor specificity of transgene expression depending on parameters of microRNA expression in normal and tumor cells was studied. It was established that microRNA suppression in tumor cells and the determination of absolute microRNA levels in tumor and normal cells are not sufficient for the adequate estimation of the possibility of specific microRNA usage in the scheme of cancer gene therapy, and particularly do not allow to exclude a significant decrease in the efficiency of the gene-therapeutic drug upon the introduction of microRNA recognition sites. These parameters are only suitable for the preliminary selection of microRNA. The effect of introduction of microRNA recognition sites on transgene expression level in target tumor cells should be validated experimentally. It is suggested that this should be done directly in the cancer gene therapy scheme with monitoring of the therapeutic transgene activity.
authors.affiliation: Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.|mshepelev@mail.ru.
authors.forename: M V
authors.initials: MV
authors.lastname: Shepelev
authors.affiliation: Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
authors.forename: S V
authors.initials: SV
authors.lastname: Kalinichenko
authors.affiliation: Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
authors.forename: P N
authors.initials: PN
authors.lastname: Vikhreva
authors.affiliation: Institute of Gene Biology, Russian Academy of Sciences, Moscow, 119334, Russia.
authors.forename: I V
authors.initials: IV
authors.lastname: Korobko
mesh_terms: D000256:Adenoviridae / Q000235:genetics; D045744:Cell Line, Tumor; D015972:Gene Expression Regulation, Neoplastic; D015316:Genetic Therapy; D005822:Genetic Vectors; D006801:Humans; D035683:MicroRNAs / Q000235:genetics*; D009369:Neoplasms / Q000235:genetics* / Q000473:pathology / Q000628:therapy*; D019076:Transgenes / Q000235:genetics
chemical_list: D035683:MicroRNAs
keywords: cancer gene therapy; microRNA; tumor specificity of expression